glp 1 in pregnancy Use of GLP-1 drugs early should not cause alarm, analysis suggests Study links GLP-1 use to

Even though the sector has faced a bit of a reality check lately following its exceptional run, the bigger picture is that global demand is growing fast, including here in the Middle East

Due to the breadth of this subject matter, we have limited this review focussing on triagonists, whereby some other promising gut hormone compounds, such as cagrilintide, reviewed elsewhere [10], are not discussed

The clinical outcomes data is robust and the benefit-risk profile, in appropriate patient populations, is well established

For people using GLP-1 drugs for weight loss, 45% plan to use them long-term, but more (51%) are likely to go on and off based on their needs